nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—CYP3A5—Paclitaxel—ovarian cancer	0.0496	0.164	CbGbCtD
Pentamidine—CYP2C8—Paclitaxel—ovarian cancer	0.0476	0.157	CbGbCtD
Pentamidine—CYP2D6—Vinorelbine—ovarian cancer	0.0432	0.143	CbGbCtD
Pentamidine—CYP3A4—Topotecan—ovarian cancer	0.039	0.129	CbGbCtD
Pentamidine—CYP3A5—Docetaxel—ovarian cancer	0.0358	0.118	CbGbCtD
Pentamidine—CYP3A4—Vinorelbine—ovarian cancer	0.0275	0.0908	CbGbCtD
Pentamidine—CYP3A4—Paclitaxel—ovarian cancer	0.0193	0.0638	CbGbCtD
Pentamidine—CYP2D6—Doxorubicin—ovarian cancer	0.0164	0.0541	CbGbCtD
Pentamidine—TRDMT1—uterus—ovarian cancer	0.0145	0.139	CbGeAlD
Pentamidine—CYP3A4—Docetaxel—ovarian cancer	0.014	0.0461	CbGbCtD
Pentamidine—TRDMT1—female reproductive system—ovarian cancer	0.013	0.125	CbGeAlD
Pentamidine—CYP3A4—Doxorubicin—ovarian cancer	0.0104	0.0344	CbGbCtD
Pentamidine—AOC1—embryo—ovarian cancer	0.0097	0.0928	CbGeAlD
Pentamidine—AOC1—decidua—ovarian cancer	0.00748	0.0716	CbGeAlD
Pentamidine—AOC1—endometrium—ovarian cancer	0.0071	0.0679	CbGeAlD
Pentamidine—AOC1—female reproductive system—ovarian cancer	0.00588	0.0563	CbGeAlD
Pentamidine—AOC1—bone marrow—ovarian cancer	0.00555	0.0531	CbGeAlD
Pentamidine—AOC1—vagina—ovarian cancer	0.00532	0.0509	CbGeAlD
Pentamidine—Ospemifene—ESR1—ovarian cancer	0.00486	1	CrCbGaD
Pentamidine—AOC1—testis—ovarian cancer	0.00474	0.0454	CbGeAlD
Pentamidine—CYP4A11—vagina—ovarian cancer	0.00442	0.0423	CbGeAlD
Pentamidine—AOC1—lymph node—ovarian cancer	0.00344	0.0329	CbGeAlD
Pentamidine—S100B—lymph node—ovarian cancer	0.003	0.0287	CbGeAlD
Pentamidine—CYP1A1—epithelium—ovarian cancer	0.00149	0.0143	CbGeAlD
Pentamidine—CYP1A1—uterine cervix—ovarian cancer	0.00148	0.0142	CbGeAlD
Pentamidine—CYP2C8—endometrium—ovarian cancer	0.00145	0.0139	CbGeAlD
Pentamidine—CYP3A5—uterine cervix—ovarian cancer	0.00145	0.0138	CbGeAlD
Pentamidine—CYP2C19—vagina—ovarian cancer	0.00124	0.0119	CbGeAlD
Pentamidine—CYP1A1—uterus—ovarian cancer	0.00123	0.0118	CbGeAlD
Pentamidine—CYP2C8—female reproductive system—ovarian cancer	0.0012	0.0115	CbGeAlD
Pentamidine—CYP1A1—female reproductive system—ovarian cancer	0.00111	0.0106	CbGeAlD
Pentamidine—CYP2C8—vagina—ovarian cancer	0.00109	0.0104	CbGeAlD
Pentamidine—CYP1A1—female gonad—ovarian cancer	0.00101	0.00965	CbGeAlD
Pentamidine—CYP1A1—vagina—ovarian cancer	0.001	0.00959	CbGeAlD
Pentamidine—CYP3A5—female gonad—ovarian cancer	0.000985	0.00943	CbGeAlD
Pentamidine—CYP3A5—vagina—ovarian cancer	0.000979	0.00938	CbGeAlD
Pentamidine—CYP2C8—testis—ovarian cancer	0.000968	0.00927	CbGeAlD
Pentamidine—CYP3A4—female reproductive system—ovarian cancer	0.000813	0.00778	CbGeAlD
Pentamidine—CYP2D6—female reproductive system—ovarian cancer	0.0008	0.00766	CbGeAlD
Pentamidine—CYP2D6—female gonad—ovarian cancer	0.000728	0.00697	CbGeAlD
Pentamidine—CYP1A1—lymph node—ovarian cancer	0.000648	0.0062	CbGeAlD
Pentamidine—CYP2D6—testis—ovarian cancer	0.000645	0.00618	CbGeAlD
Pentamidine—Dry mouth—Paclitaxel—ovarian cancer	0.000307	0.000735	CcSEcCtD
Pentamidine—Mood swings—Doxorubicin—ovarian cancer	0.000307	0.000735	CcSEcCtD
Pentamidine—Diarrhoea—Vinorelbine—ovarian cancer	0.000307	0.000733	CcSEcCtD
Pentamidine—Dysgeusia—Docetaxel—ovarian cancer	0.000306	0.000733	CcSEcCtD
Pentamidine—Nausea—Melphalan—ovarian cancer	0.000305	0.000728	CcSEcCtD
Pentamidine—Confusional state—Paclitaxel—ovarian cancer	0.000304	0.000727	CcSEcCtD
Pentamidine—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000304	0.000727	CcSEcCtD
Pentamidine—Influenza—Epirubicin—ovarian cancer	0.000303	0.000724	CcSEcCtD
Pentamidine—Asthma—Epirubicin—ovarian cancer	0.000303	0.000724	CcSEcCtD
Pentamidine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000301	0.000721	CcSEcCtD
Pentamidine—Eosinophilia—Epirubicin—ovarian cancer	0.0003	0.000717	CcSEcCtD
Pentamidine—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000299	0.000716	CcSEcCtD
Pentamidine—Infection—Paclitaxel—ovarian cancer	0.000299	0.000716	CcSEcCtD
Pentamidine—Dry skin—Doxorubicin—ovarian cancer	0.000297	0.000711	CcSEcCtD
Pentamidine—Pancreatitis—Epirubicin—ovarian cancer	0.000297	0.00071	CcSEcCtD
Pentamidine—Shock—Paclitaxel—ovarian cancer	0.000296	0.000709	CcSEcCtD
Pentamidine—Dizziness—Vinorelbine—ovarian cancer	0.000296	0.000708	CcSEcCtD
Pentamidine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000295	0.000706	CcSEcCtD
Pentamidine—Tachycardia—Paclitaxel—ovarian cancer	0.000294	0.000703	CcSEcCtD
Pentamidine—Bronchitis—Epirubicin—ovarian cancer	0.000291	0.000697	CcSEcCtD
Pentamidine—Anaemia—Docetaxel—ovarian cancer	0.000289	0.000692	CcSEcCtD
Pentamidine—Pancytopenia—Epirubicin—ovarian cancer	0.000288	0.000688	CcSEcCtD
Pentamidine—Anorexia—Paclitaxel—ovarian cancer	0.000287	0.000687	CcSEcCtD
Pentamidine—Gastritis—Doxorubicin—ovarian cancer	0.000287	0.000686	CcSEcCtD
Pentamidine—Vomiting—Vinorelbine—ovarian cancer	0.000285	0.000681	CcSEcCtD
Pentamidine—Neutropenia—Epirubicin—ovarian cancer	0.000283	0.000677	CcSEcCtD
Pentamidine—Rash—Vinorelbine—ovarian cancer	0.000282	0.000676	CcSEcCtD
Pentamidine—Dermatitis—Vinorelbine—ovarian cancer	0.000282	0.000675	CcSEcCtD
Pentamidine—Hypotension—Paclitaxel—ovarian cancer	0.000282	0.000673	CcSEcCtD
Pentamidine—Headache—Vinorelbine—ovarian cancer	0.000281	0.000671	CcSEcCtD
Pentamidine—Syncope—Docetaxel—ovarian cancer	0.000281	0.000671	CcSEcCtD
Pentamidine—Influenza—Doxorubicin—ovarian cancer	0.00028	0.00067	CcSEcCtD
Pentamidine—Asthma—Doxorubicin—ovarian cancer	0.00028	0.00067	CcSEcCtD
Pentamidine—Leukopenia—Docetaxel—ovarian cancer	0.00028	0.00067	CcSEcCtD
Pentamidine—Eosinophilia—Doxorubicin—ovarian cancer	0.000278	0.000664	CcSEcCtD
Pentamidine—Palpitations—Docetaxel—ovarian cancer	0.000277	0.000661	CcSEcCtD
Pentamidine—Loss of consciousness—Docetaxel—ovarian cancer	0.000275	0.000658	CcSEcCtD
Pentamidine—Pancreatitis—Doxorubicin—ovarian cancer	0.000275	0.000657	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000275	0.000657	CcSEcCtD
Pentamidine—Hyperglycaemia—Epirubicin—ovarian cancer	0.000273	0.000654	CcSEcCtD
Pentamidine—Cough—Docetaxel—ovarian cancer	0.000273	0.000653	CcSEcCtD
Pentamidine—Insomnia—Paclitaxel—ovarian cancer	0.000273	0.000652	CcSEcCtD
Pentamidine—Convulsion—Docetaxel—ovarian cancer	0.000271	0.000648	CcSEcCtD
Pentamidine—Paraesthesia—Paclitaxel—ovarian cancer	0.000271	0.000647	CcSEcCtD
Pentamidine—Hypertension—Docetaxel—ovarian cancer	0.00027	0.000646	CcSEcCtD
Pentamidine—Drowsiness—Epirubicin—ovarian cancer	0.00027	0.000646	CcSEcCtD
Pentamidine—Bronchitis—Doxorubicin—ovarian cancer	0.00027	0.000645	CcSEcCtD
Pentamidine—Dyspnoea—Paclitaxel—ovarian cancer	0.000269	0.000642	CcSEcCtD
Pentamidine—Somnolence—Paclitaxel—ovarian cancer	0.000268	0.000641	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000268	0.00064	CcSEcCtD
Pentamidine—Myalgia—Docetaxel—ovarian cancer	0.000266	0.000637	CcSEcCtD
Pentamidine—Chest pain—Docetaxel—ovarian cancer	0.000266	0.000637	CcSEcCtD
Pentamidine—Arthralgia—Docetaxel—ovarian cancer	0.000266	0.000637	CcSEcCtD
Pentamidine—Pancytopenia—Doxorubicin—ovarian cancer	0.000266	0.000637	CcSEcCtD
Pentamidine—Nausea—Vinorelbine—ovarian cancer	0.000266	0.000636	CcSEcCtD
Pentamidine—Renal failure—Epirubicin—ovarian cancer	0.000266	0.000635	CcSEcCtD
Pentamidine—Dyspepsia—Paclitaxel—ovarian cancer	0.000265	0.000634	CcSEcCtD
Pentamidine—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000265	0.000633	CcSEcCtD
Pentamidine—Stomatitis—Epirubicin—ovarian cancer	0.000263	0.00063	CcSEcCtD
Pentamidine—Conjunctivitis—Epirubicin—ovarian cancer	0.000263	0.000628	CcSEcCtD
Pentamidine—Neutropenia—Doxorubicin—ovarian cancer	0.000262	0.000627	CcSEcCtD
Pentamidine—Decreased appetite—Paclitaxel—ovarian cancer	0.000262	0.000626	CcSEcCtD
Pentamidine—Dry mouth—Docetaxel—ovarian cancer	0.000261	0.000623	CcSEcCtD
Pentamidine—Fatigue—Paclitaxel—ovarian cancer	0.00026	0.000621	CcSEcCtD
Pentamidine—Pain—Paclitaxel—ovarian cancer	0.000258	0.000616	CcSEcCtD
Pentamidine—Constipation—Paclitaxel—ovarian cancer	0.000258	0.000616	CcSEcCtD
Pentamidine—Haematuria—Epirubicin—ovarian cancer	0.000258	0.000616	CcSEcCtD
Pentamidine—Confusional state—Docetaxel—ovarian cancer	0.000258	0.000616	CcSEcCtD
Pentamidine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000255	0.000611	CcSEcCtD
Pentamidine—Infection—Docetaxel—ovarian cancer	0.000254	0.000607	CcSEcCtD
Pentamidine—Sinusitis—Epirubicin—ovarian cancer	0.000253	0.000606	CcSEcCtD
Pentamidine—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000253	0.000605	CcSEcCtD
Pentamidine—Shock—Docetaxel—ovarian cancer	0.000251	0.000601	CcSEcCtD
Pentamidine—Thrombocytopenia—Docetaxel—ovarian cancer	0.00025	0.000598	CcSEcCtD
Pentamidine—Drowsiness—Doxorubicin—ovarian cancer	0.00025	0.000598	CcSEcCtD
Pentamidine—Tachycardia—Docetaxel—ovarian cancer	0.000249	0.000596	CcSEcCtD
Pentamidine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000248	0.000594	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000248	0.000593	CcSEcCtD
Pentamidine—Bradycardia—Epirubicin—ovarian cancer	0.000247	0.00059	CcSEcCtD
Pentamidine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000246	0.000589	CcSEcCtD
Pentamidine—Renal failure—Doxorubicin—ovarian cancer	0.000246	0.000588	CcSEcCtD
Pentamidine—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000245	0.000586	CcSEcCtD
Pentamidine—Stomatitis—Doxorubicin—ovarian cancer	0.000244	0.000583	CcSEcCtD
Pentamidine—Anorexia—Docetaxel—ovarian cancer	0.000243	0.000582	CcSEcCtD
Pentamidine—Rhinitis—Epirubicin—ovarian cancer	0.000243	0.000581	CcSEcCtD
Pentamidine—Conjunctivitis—Doxorubicin—ovarian cancer	0.000243	0.000581	CcSEcCtD
Pentamidine—Hepatitis—Epirubicin—ovarian cancer	0.000242	0.00058	CcSEcCtD
Pentamidine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000241	0.000577	CcSEcCtD
Pentamidine—Pharyngitis—Epirubicin—ovarian cancer	0.000241	0.000576	CcSEcCtD
Pentamidine—Urticaria—Paclitaxel—ovarian cancer	0.000239	0.000572	CcSEcCtD
Pentamidine—Oedema peripheral—Epirubicin—ovarian cancer	0.000239	0.000571	CcSEcCtD
Pentamidine—Hypotension—Docetaxel—ovarian cancer	0.000239	0.000571	CcSEcCtD
Pentamidine—Haematuria—Doxorubicin—ovarian cancer	0.000238	0.00057	CcSEcCtD
Pentamidine—Abdominal pain—Paclitaxel—ovarian cancer	0.000238	0.00057	CcSEcCtD
Pentamidine—Body temperature increased—Paclitaxel—ovarian cancer	0.000238	0.00057	CcSEcCtD
Pentamidine—Sinusitis—Doxorubicin—ovarian cancer	0.000234	0.000561	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000233	0.000556	CcSEcCtD
Pentamidine—Insomnia—Docetaxel—ovarian cancer	0.000231	0.000552	CcSEcCtD
Pentamidine—Paraesthesia—Docetaxel—ovarian cancer	0.000229	0.000548	CcSEcCtD
Pentamidine—Erythema multiforme—Epirubicin—ovarian cancer	0.000229	0.000548	CcSEcCtD
Pentamidine—Bradycardia—Doxorubicin—ovarian cancer	0.000228	0.000546	CcSEcCtD
Pentamidine—Dyspnoea—Docetaxel—ovarian cancer	0.000228	0.000545	CcSEcCtD
Pentamidine—Somnolence—Docetaxel—ovarian cancer	0.000227	0.000543	CcSEcCtD
Pentamidine—Flushing—Epirubicin—ovarian cancer	0.000225	0.000538	CcSEcCtD
Pentamidine—Rhinitis—Doxorubicin—ovarian cancer	0.000225	0.000538	CcSEcCtD
Pentamidine—Dyspepsia—Docetaxel—ovarian cancer	0.000225	0.000538	CcSEcCtD
Pentamidine—Hepatitis—Doxorubicin—ovarian cancer	0.000224	0.000537	CcSEcCtD
Pentamidine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000223	0.000534	CcSEcCtD
Pentamidine—Pharyngitis—Doxorubicin—ovarian cancer	0.000223	0.000533	CcSEcCtD
Pentamidine—Decreased appetite—Docetaxel—ovarian cancer	0.000222	0.000531	CcSEcCtD
Pentamidine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000222	0.000531	CcSEcCtD
Pentamidine—Oedema peripheral—Doxorubicin—ovarian cancer	0.000221	0.000529	CcSEcCtD
Pentamidine—Fatigue—Docetaxel—ovarian cancer	0.00022	0.000527	CcSEcCtD
Pentamidine—Pain—Docetaxel—ovarian cancer	0.000218	0.000522	CcSEcCtD
Pentamidine—Constipation—Docetaxel—ovarian cancer	0.000218	0.000522	CcSEcCtD
Pentamidine—Chills—Epirubicin—ovarian cancer	0.000218	0.00052	CcSEcCtD
Pentamidine—Arrhythmia—Epirubicin—ovarian cancer	0.000217	0.000518	CcSEcCtD
Pentamidine—Asthenia—Paclitaxel—ovarian cancer	0.000216	0.000517	CcSEcCtD
Pentamidine—Pruritus—Paclitaxel—ovarian cancer	0.000213	0.00051	CcSEcCtD
Pentamidine—Erythema multiforme—Doxorubicin—ovarian cancer	0.000212	0.000507	CcSEcCtD
Pentamidine—Erythema—Epirubicin—ovarian cancer	0.000211	0.000505	CcSEcCtD
Pentamidine—Feeling abnormal—Docetaxel—ovarian cancer	0.00021	0.000503	CcSEcCtD
Pentamidine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000209	0.000499	CcSEcCtD
Pentamidine—Flushing—Doxorubicin—ovarian cancer	0.000208	0.000498	CcSEcCtD
Pentamidine—Tension—Epirubicin—ovarian cancer	0.000207	0.000495	CcSEcCtD
Pentamidine—Dysgeusia—Epirubicin—ovarian cancer	0.000207	0.000494	CcSEcCtD
Pentamidine—Diarrhoea—Paclitaxel—ovarian cancer	0.000206	0.000493	CcSEcCtD
Pentamidine—Nervousness—Epirubicin—ovarian cancer	0.000205	0.00049	CcSEcCtD
Pentamidine—Abdominal pain—Docetaxel—ovarian cancer	0.000202	0.000483	CcSEcCtD
Pentamidine—Body temperature increased—Docetaxel—ovarian cancer	0.000202	0.000483	CcSEcCtD
Pentamidine—Chills—Doxorubicin—ovarian cancer	0.000201	0.000481	CcSEcCtD
Pentamidine—Arrhythmia—Doxorubicin—ovarian cancer	0.0002	0.000479	CcSEcCtD
Pentamidine—Dizziness—Paclitaxel—ovarian cancer	0.000199	0.000477	CcSEcCtD
Pentamidine—Vision blurred—Epirubicin—ovarian cancer	0.000199	0.000476	CcSEcCtD
Pentamidine—Erythema—Doxorubicin—ovarian cancer	0.000195	0.000467	CcSEcCtD
Pentamidine—Anaemia—Epirubicin—ovarian cancer	0.000195	0.000467	CcSEcCtD
Pentamidine—Tension—Doxorubicin—ovarian cancer	0.000192	0.000458	CcSEcCtD
Pentamidine—Vomiting—Paclitaxel—ovarian cancer	0.000192	0.000458	CcSEcCtD
Pentamidine—Dysgeusia—Doxorubicin—ovarian cancer	0.000191	0.000457	CcSEcCtD
Pentamidine—Rash—Paclitaxel—ovarian cancer	0.00019	0.000454	CcSEcCtD
Pentamidine—Dermatitis—Paclitaxel—ovarian cancer	0.00019	0.000454	CcSEcCtD
Pentamidine—Nervousness—Doxorubicin—ovarian cancer	0.00019	0.000454	CcSEcCtD
Pentamidine—Vertigo—Epirubicin—ovarian cancer	0.00019	0.000454	CcSEcCtD
Pentamidine—Syncope—Epirubicin—ovarian cancer	0.000189	0.000453	CcSEcCtD
Pentamidine—Leukopenia—Epirubicin—ovarian cancer	0.000189	0.000452	CcSEcCtD
Pentamidine—Headache—Paclitaxel—ovarian cancer	0.000189	0.000451	CcSEcCtD
Pentamidine—Hypersensitivity—Docetaxel—ovarian cancer	0.000188	0.00045	CcSEcCtD
Pentamidine—Palpitations—Epirubicin—ovarian cancer	0.000187	0.000446	CcSEcCtD
Pentamidine—Loss of consciousness—Epirubicin—ovarian cancer	0.000186	0.000444	CcSEcCtD
Pentamidine—Cough—Epirubicin—ovarian cancer	0.000184	0.00044	CcSEcCtD
Pentamidine—Vision blurred—Doxorubicin—ovarian cancer	0.000184	0.00044	CcSEcCtD
Pentamidine—Asthenia—Docetaxel—ovarian cancer	0.000183	0.000438	CcSEcCtD
Pentamidine—Convulsion—Epirubicin—ovarian cancer	0.000183	0.000437	CcSEcCtD
Pentamidine—Hypertension—Epirubicin—ovarian cancer	0.000182	0.000436	CcSEcCtD
Pentamidine—Pruritus—Docetaxel—ovarian cancer	0.000181	0.000432	CcSEcCtD
Pentamidine—Anaemia—Doxorubicin—ovarian cancer	0.000181	0.000432	CcSEcCtD
Pentamidine—Myalgia—Epirubicin—ovarian cancer	0.00018	0.00043	CcSEcCtD
Pentamidine—Arthralgia—Epirubicin—ovarian cancer	0.00018	0.00043	CcSEcCtD
Pentamidine—Chest pain—Epirubicin—ovarian cancer	0.00018	0.00043	CcSEcCtD
Pentamidine—Anxiety—Epirubicin—ovarian cancer	0.000179	0.000428	CcSEcCtD
Pentamidine—Nausea—Paclitaxel—ovarian cancer	0.000179	0.000428	CcSEcCtD
Pentamidine—Discomfort—Epirubicin—ovarian cancer	0.000178	0.000425	CcSEcCtD
Pentamidine—Dry mouth—Epirubicin—ovarian cancer	0.000176	0.00042	CcSEcCtD
Pentamidine—Vertigo—Doxorubicin—ovarian cancer	0.000175	0.00042	CcSEcCtD
Pentamidine—Syncope—Doxorubicin—ovarian cancer	0.000175	0.000419	CcSEcCtD
Pentamidine—Leukopenia—Doxorubicin—ovarian cancer	0.000175	0.000418	CcSEcCtD
Pentamidine—Diarrhoea—Docetaxel—ovarian cancer	0.000175	0.000418	CcSEcCtD
Pentamidine—Confusional state—Epirubicin—ovarian cancer	0.000174	0.000415	CcSEcCtD
Pentamidine—Palpitations—Doxorubicin—ovarian cancer	0.000173	0.000413	CcSEcCtD
Pentamidine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000172	0.000412	CcSEcCtD
Pentamidine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000172	0.000411	CcSEcCtD
Pentamidine—Infection—Epirubicin—ovarian cancer	0.000171	0.000409	CcSEcCtD
Pentamidine—Cough—Doxorubicin—ovarian cancer	0.00017	0.000408	CcSEcCtD
Pentamidine—Shock—Epirubicin—ovarian cancer	0.000169	0.000405	CcSEcCtD
Pentamidine—Convulsion—Doxorubicin—ovarian cancer	0.000169	0.000405	CcSEcCtD
Pentamidine—Dizziness—Docetaxel—ovarian cancer	0.000169	0.000404	CcSEcCtD
Pentamidine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000169	0.000403	CcSEcCtD
Pentamidine—Hypertension—Doxorubicin—ovarian cancer	0.000169	0.000403	CcSEcCtD
Pentamidine—Tachycardia—Epirubicin—ovarian cancer	0.000168	0.000402	CcSEcCtD
Pentamidine—Myalgia—Doxorubicin—ovarian cancer	0.000166	0.000398	CcSEcCtD
Pentamidine—Chest pain—Doxorubicin—ovarian cancer	0.000166	0.000398	CcSEcCtD
Pentamidine—Arthralgia—Doxorubicin—ovarian cancer	0.000166	0.000398	CcSEcCtD
Pentamidine—Anxiety—Doxorubicin—ovarian cancer	0.000166	0.000396	CcSEcCtD
Pentamidine—Discomfort—Doxorubicin—ovarian cancer	0.000164	0.000393	CcSEcCtD
Pentamidine—Anorexia—Epirubicin—ovarian cancer	0.000164	0.000393	CcSEcCtD
Pentamidine—Dry mouth—Doxorubicin—ovarian cancer	0.000163	0.000389	CcSEcCtD
Pentamidine—Vomiting—Docetaxel—ovarian cancer	0.000162	0.000388	CcSEcCtD
Pentamidine—Rash—Docetaxel—ovarian cancer	0.000161	0.000385	CcSEcCtD
Pentamidine—Hypotension—Epirubicin—ovarian cancer	0.000161	0.000385	CcSEcCtD
Pentamidine—Dermatitis—Docetaxel—ovarian cancer	0.000161	0.000385	CcSEcCtD
Pentamidine—Confusional state—Doxorubicin—ovarian cancer	0.000161	0.000384	CcSEcCtD
Pentamidine—Headache—Docetaxel—ovarian cancer	0.00016	0.000383	CcSEcCtD
Pentamidine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000159	0.000381	CcSEcCtD
Pentamidine—Infection—Doxorubicin—ovarian cancer	0.000158	0.000379	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000157	0.000375	CcSEcCtD
Pentamidine—Shock—Doxorubicin—ovarian cancer	0.000157	0.000375	CcSEcCtD
Pentamidine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000156	0.000373	CcSEcCtD
Pentamidine—Insomnia—Epirubicin—ovarian cancer	0.000156	0.000373	CcSEcCtD
Pentamidine—Tachycardia—Doxorubicin—ovarian cancer	0.000156	0.000372	CcSEcCtD
Pentamidine—Paraesthesia—Epirubicin—ovarian cancer	0.000155	0.00037	CcSEcCtD
Pentamidine—Dyspnoea—Epirubicin—ovarian cancer	0.000154	0.000367	CcSEcCtD
Pentamidine—Somnolence—Epirubicin—ovarian cancer	0.000153	0.000366	CcSEcCtD
Pentamidine—Anorexia—Doxorubicin—ovarian cancer	0.000152	0.000363	CcSEcCtD
Pentamidine—Nausea—Docetaxel—ovarian cancer	0.000152	0.000363	CcSEcCtD
Pentamidine—Dyspepsia—Epirubicin—ovarian cancer	0.000152	0.000363	CcSEcCtD
Pentamidine—Decreased appetite—Epirubicin—ovarian cancer	0.00015	0.000358	CcSEcCtD
Pentamidine—Hypotension—Doxorubicin—ovarian cancer	0.000149	0.000356	CcSEcCtD
Pentamidine—Fatigue—Epirubicin—ovarian cancer	0.000149	0.000355	CcSEcCtD
Pentamidine—Pain—Epirubicin—ovarian cancer	0.000147	0.000352	CcSEcCtD
Pentamidine—Constipation—Epirubicin—ovarian cancer	0.000147	0.000352	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000145	0.000347	CcSEcCtD
Pentamidine—Insomnia—Doxorubicin—ovarian cancer	0.000144	0.000345	CcSEcCtD
Pentamidine—Paraesthesia—Doxorubicin—ovarian cancer	0.000143	0.000342	CcSEcCtD
Pentamidine—Dyspnoea—Doxorubicin—ovarian cancer	0.000142	0.00034	CcSEcCtD
Pentamidine—Feeling abnormal—Epirubicin—ovarian cancer	0.000142	0.000339	CcSEcCtD
Pentamidine—Somnolence—Doxorubicin—ovarian cancer	0.000142	0.000339	CcSEcCtD
Pentamidine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000141	0.000337	CcSEcCtD
Pentamidine—Dyspepsia—Doxorubicin—ovarian cancer	0.00014	0.000336	CcSEcCtD
Pentamidine—Decreased appetite—Doxorubicin—ovarian cancer	0.000139	0.000331	CcSEcCtD
Pentamidine—Fatigue—Doxorubicin—ovarian cancer	0.000137	0.000329	CcSEcCtD
Pentamidine—Urticaria—Epirubicin—ovarian cancer	0.000137	0.000327	CcSEcCtD
Pentamidine—Pain—Doxorubicin—ovarian cancer	0.000136	0.000326	CcSEcCtD
Pentamidine—Constipation—Doxorubicin—ovarian cancer	0.000136	0.000326	CcSEcCtD
Pentamidine—Abdominal pain—Epirubicin—ovarian cancer	0.000136	0.000326	CcSEcCtD
Pentamidine—Body temperature increased—Epirubicin—ovarian cancer	0.000136	0.000326	CcSEcCtD
Pentamidine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000131	0.000314	CcSEcCtD
Pentamidine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00013	0.000312	CcSEcCtD
Pentamidine—Hypersensitivity—Epirubicin—ovarian cancer	0.000127	0.000304	CcSEcCtD
Pentamidine—Urticaria—Doxorubicin—ovarian cancer	0.000127	0.000303	CcSEcCtD
Pentamidine—Abdominal pain—Doxorubicin—ovarian cancer	0.000126	0.000301	CcSEcCtD
Pentamidine—Body temperature increased—Doxorubicin—ovarian cancer	0.000126	0.000301	CcSEcCtD
Pentamidine—Asthenia—Epirubicin—ovarian cancer	0.000124	0.000296	CcSEcCtD
Pentamidine—Pruritus—Epirubicin—ovarian cancer	0.000122	0.000291	CcSEcCtD
Pentamidine—Diarrhoea—Epirubicin—ovarian cancer	0.000118	0.000282	CcSEcCtD
Pentamidine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000117	0.000281	CcSEcCtD
Pentamidine—Asthenia—Doxorubicin—ovarian cancer	0.000114	0.000273	CcSEcCtD
Pentamidine—Dizziness—Epirubicin—ovarian cancer	0.000114	0.000272	CcSEcCtD
Pentamidine—Pruritus—Doxorubicin—ovarian cancer	0.000113	0.00027	CcSEcCtD
Pentamidine—Vomiting—Epirubicin—ovarian cancer	0.00011	0.000262	CcSEcCtD
Pentamidine—Diarrhoea—Doxorubicin—ovarian cancer	0.000109	0.000261	CcSEcCtD
Pentamidine—Rash—Epirubicin—ovarian cancer	0.000109	0.00026	CcSEcCtD
Pentamidine—Dermatitis—Epirubicin—ovarian cancer	0.000109	0.00026	CcSEcCtD
Pentamidine—Headache—Epirubicin—ovarian cancer	0.000108	0.000258	CcSEcCtD
Pentamidine—Dizziness—Doxorubicin—ovarian cancer	0.000105	0.000252	CcSEcCtD
Pentamidine—Nausea—Epirubicin—ovarian cancer	0.000102	0.000245	CcSEcCtD
Pentamidine—Vomiting—Doxorubicin—ovarian cancer	0.000101	0.000242	CcSEcCtD
Pentamidine—Rash—Doxorubicin—ovarian cancer	0.000101	0.00024	CcSEcCtD
Pentamidine—Dermatitis—Doxorubicin—ovarian cancer	0.0001	0.00024	CcSEcCtD
Pentamidine—Headache—Doxorubicin—ovarian cancer	9.99e-05	0.000239	CcSEcCtD
Pentamidine—Nausea—Doxorubicin—ovarian cancer	9.47e-05	0.000226	CcSEcCtD
Pentamidine—S100B—Innate Immune System—MAPK3—ovarian cancer	8.61e-05	0.000507	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PPP2R1A—ovarian cancer	8.56e-05	0.000504	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.55e-05	0.000504	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—NME2—ovarian cancer	8.32e-05	0.00049	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	8.22e-05	0.000485	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—MAPK1—ovarian cancer	8.19e-05	0.000483	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—EGFR—ovarian cancer	8.19e-05	0.000483	CbGpPWpGaD
Pentamidine—S100B—Immune System—CDH1—ovarian cancer	8.15e-05	0.000481	CbGpPWpGaD
Pentamidine—S100B—Immune System—PIK3CD—ovarian cancer	7.79e-05	0.000459	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—KRAS—ovarian cancer	7.73e-05	0.000456	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	7.69e-05	0.000453	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.51e-05	0.000443	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—NME2—ovarian cancer	7.42e-05	0.000437	CbGpPWpGaD
Pentamidine—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	7.32e-05	0.000431	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	7.31e-05	0.000431	CbGpPWpGaD
Pentamidine—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	7.22e-05	0.000426	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—PIK3CA—ovarian cancer	7.11e-05	0.000419	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	7.05e-05	0.000416	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—FASN—ovarian cancer	7.04e-05	0.000415	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	6.99e-05	0.000412	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—SLC5A5—ovarian cancer	6.92e-05	0.000408	CbGpPWpGaD
Pentamidine—S100B—Immune System—ERBB2—ovarian cancer	6.88e-05	0.000405	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NME2—ovarian cancer	6.83e-05	0.000402	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TERT—ovarian cancer	6.8e-05	0.000401	CbGpPWpGaD
Pentamidine—S100B—Immune System—MTOR—ovarian cancer	6.79e-05	0.0004	CbGpPWpGaD
Pentamidine—S100B—Immune System—PIK3CB—ovarian cancer	6.79e-05	0.0004	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—SLC2A1—ovarian cancer	6.69e-05	0.000394	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—HRAS—ovarian cancer	6.57e-05	0.000387	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.55e-05	0.000386	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—CYP1B1—ovarian cancer	6.41e-05	0.000378	CbGpPWpGaD
Pentamidine—S100B—Immune System—CDKN1B—ovarian cancer	6.37e-05	0.000376	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	6.3e-05	0.000371	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—IL6—ovarian cancer	6.29e-05	0.000371	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CAV1—ovarian cancer	6.29e-05	0.000371	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	6.27e-05	0.00037	CbGpPWpGaD
Pentamidine—S100B—Immune System—IL2—ovarian cancer	6.23e-05	0.000367	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYTB—ovarian cancer	6.19e-05	0.000365	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—ESR1—ovarian cancer	6.06e-05	0.000357	CbGpPWpGaD
Pentamidine—S100B—Immune System—CTNNB1—ovarian cancer	6.02e-05	0.000355	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—IL6ST—ovarian cancer	5.96e-05	0.000351	CbGpPWpGaD
Pentamidine—S100B—Immune System—PTEN—ovarian cancer	5.87e-05	0.000346	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CYTB—ovarian cancer	5.84e-05	0.000344	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—AKT1—ovarian cancer	5.8e-05	0.000342	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NME2—ovarian cancer	5.78e-05	0.000341	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	5.75e-05	0.000339	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PIK3CG—ovarian cancer	5.73e-05	0.000338	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—APC—ovarian cancer	5.73e-05	0.000338	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	5.71e-05	0.000337	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PPP2R1A—ovarian cancer	5.69e-05	0.000335	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.66e-05	0.000333	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—BRIP1—ovarian cancer	5.41e-05	0.000319	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PPP1CC—ovarian cancer	5.41e-05	0.000319	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYTB—ovarian cancer	5.36e-05	0.000316	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—ABCB1—ovarian cancer	5.28e-05	0.000311	CbGpPWpGaD
Pentamidine—S100B—Immune System—STAT3—ovarian cancer	5.25e-05	0.000309	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	5.24e-05	0.000309	CbGpPWpGaD
Pentamidine—S100B—Immune System—NRAS—ovarian cancer	5.23e-05	0.000308	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—TYMS—ovarian cancer	5.18e-05	0.000306	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	5.13e-05	0.000303	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—BRIP1—ovarian cancer	5.11e-05	0.000301	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PPP1CC—ovarian cancer	5.11e-05	0.000301	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PIK3CD—ovarian cancer	5.04e-05	0.000297	CbGpPWpGaD
Pentamidine—S100B—Immune System—MAPK3—ovarian cancer	5.01e-05	0.000295	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	4.91e-05	0.000289	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYTB—ovarian cancer	4.78e-05	0.000282	CbGpPWpGaD
Pentamidine—S100B—Immune System—MAPK1—ovarian cancer	4.77e-05	0.000281	CbGpPWpGaD
Pentamidine—S100B—Immune System—EGFR—ovarian cancer	4.77e-05	0.000281	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PPP1CC—ovarian cancer	4.68e-05	0.000276	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—BRIP1—ovarian cancer	4.68e-05	0.000276	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	4.67e-05	0.000276	CbGpPWpGaD
Pentamidine—S100B—Immune System—KRAS—ovarian cancer	4.5e-05	0.000266	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NME2—ovarian cancer	4.46e-05	0.000263	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—ERBB2—ovarian cancer	4.45e-05	0.000262	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYTB—ovarian cancer	4.4e-05	0.000259	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MTOR—ovarian cancer	4.39e-05	0.000259	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PIK3CB—ovarian cancer	4.39e-05	0.000259	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CXCL8—ovarian cancer	4.22e-05	0.000249	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—BRIP1—ovarian cancer	4.18e-05	0.000246	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PPP1CC—ovarian cancer	4.18e-05	0.000246	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—CAV1—ovarian cancer	4.18e-05	0.000246	CbGpPWpGaD
Pentamidine—S100B—Immune System—PIK3CA—ovarian cancer	4.14e-05	0.000244	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CDKN1B—ovarian cancer	4.12e-05	0.000243	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CASP3—ovarian cancer	4.04e-05	0.000238	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—IL2—ovarian cancer	4.03e-05	0.000238	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	4e-05	0.000236	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.99e-05	0.000235	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CCND1—ovarian cancer	3.93e-05	0.000232	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CTNNB1—ovarian cancer	3.89e-05	0.000229	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PPP1CC—ovarian cancer	3.85e-05	0.000227	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—BRIP1—ovarian cancer	3.85e-05	0.000227	CbGpPWpGaD
Pentamidine—S100B—Immune System—HRAS—ovarian cancer	3.83e-05	0.000226	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MMP9—ovarian cancer	3.82e-05	0.000225	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CG—ovarian cancer	3.81e-05	0.000224	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PTEN—ovarian cancer	3.79e-05	0.000224	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYTB—ovarian cancer	3.73e-05	0.00022	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.72e-05	0.000219	CbGpPWpGaD
Pentamidine—S100B—Immune System—IL6—ovarian cancer	3.66e-05	0.000216	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	3.64e-05	0.000215	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—YAP1—ovarian cancer	3.63e-05	0.000214	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—YAP1—ovarian cancer	3.43e-05	0.000202	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—VEGFA—ovarian cancer	3.43e-05	0.000202	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.41e-05	0.000201	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—STAT3—ovarian cancer	3.39e-05	0.0002	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.39e-05	0.0002	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—NRAS—ovarian cancer	3.38e-05	0.000199	CbGpPWpGaD
Pentamidine—S100B—Immune System—AKT1—ovarian cancer	3.38e-05	0.000199	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CD—ovarian cancer	3.35e-05	0.000197	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—BRIP1—ovarian cancer	3.26e-05	0.000192	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PPP1CC—ovarian cancer	3.26e-05	0.000192	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MAPK3—ovarian cancer	3.24e-05	0.000191	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MYC—ovarian cancer	3.15e-05	0.000186	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—YAP1—ovarian cancer	3.14e-05	0.000185	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.11e-05	0.000183	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MAPK1—ovarian cancer	3.08e-05	0.000182	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—EGFR—ovarian cancer	3.08e-05	0.000182	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.05e-05	0.00018	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.98e-05	0.000176	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—FASN—ovarian cancer	2.96e-05	0.000174	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CB—ovarian cancer	2.92e-05	0.000172	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—KRAS—ovarian cancer	2.91e-05	0.000172	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—SLC5A5—ovarian cancer	2.91e-05	0.000171	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYTB—ovarian cancer	2.88e-05	0.00017	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—SLC2A1—ovarian cancer	2.81e-05	0.000166	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—YAP1—ovarian cancer	2.8e-05	0.000165	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—FASN—ovarian cancer	2.79e-05	0.000165	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.77e-05	0.000164	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—SLC5A5—ovarian cancer	2.75e-05	0.000162	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.73e-05	0.000161	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYP1B1—ovarian cancer	2.69e-05	0.000159	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PIK3CA—ovarian cancer	2.68e-05	0.000158	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—SLC2A1—ovarian cancer	2.65e-05	0.000156	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.6e-05	0.000153	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TP53—ovarian cancer	2.59e-05	0.000153	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—YAP1—ovarian cancer	2.58e-05	0.000152	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—FASN—ovarian cancer	2.56e-05	0.000151	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CYP1B1—ovarian cancer	2.54e-05	0.00015	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PTEN—ovarian cancer	2.52e-05	0.000149	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—SLC5A5—ovarian cancer	2.52e-05	0.000148	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—BRIP1—ovarian cancer	2.51e-05	0.000148	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	2.51e-05	0.000148	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—HRAS—ovarian cancer	2.48e-05	0.000146	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.44e-05	0.000144	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—SLC2A1—ovarian cancer	2.43e-05	0.000143	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	2.39e-05	0.000141	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.38e-05	0.00014	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.37e-05	0.00014	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—IL6—ovarian cancer	2.37e-05	0.00014	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP1B1—ovarian cancer	2.33e-05	0.000137	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—FASN—ovarian cancer	2.29e-05	0.000135	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PPP2R1A—ovarian cancer	2.26e-05	0.000133	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—SLC5A5—ovarian cancer	2.25e-05	0.000133	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.25e-05	0.000132	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ABCB1—ovarian cancer	2.22e-05	0.000131	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—AKT1—ovarian cancer	2.19e-05	0.000129	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—YAP1—ovarian cancer	2.18e-05	0.000129	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—TYMS—ovarian cancer	2.18e-05	0.000128	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—SLC2A1—ovarian cancer	2.17e-05	0.000128	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.16e-05	0.000127	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.13e-05	0.000125	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—FASN—ovarian cancer	2.1e-05	0.000124	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ABCB1—ovarian cancer	2.1e-05	0.000123	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP1B1—ovarian cancer	2.08e-05	0.000123	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	2.07e-05	0.000122	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—SLC5A5—ovarian cancer	2.07e-05	0.000122	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.06e-05	0.000121	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—TYMS—ovarian cancer	2.06e-05	0.000121	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—SLC2A1—ovarian cancer	2e-05	0.000118	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ABCB1—ovarian cancer	1.92e-05	0.000113	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP1B1—ovarian cancer	1.91e-05	0.000113	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.9e-05	0.000112	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—TYMS—ovarian cancer	1.89e-05	0.000111	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	1.85e-05	0.000109	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.84e-05	0.000108	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—FASN—ovarian cancer	1.78e-05	0.000105	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CA—ovarian cancer	1.78e-05	0.000105	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CAV1—ovarian cancer	1.75e-05	0.000103	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SLC5A5—ovarian cancer	1.75e-05	0.000103	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ABCB1—ovarian cancer	1.71e-05	0.000101	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	1.7e-05	0.0001	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SLC2A1—ovarian cancer	1.69e-05	9.97e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—YAP1—ovarian cancer	1.69e-05	9.94e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—TYMS—ovarian cancer	1.68e-05	9.92e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CAV1—ovarian cancer	1.66e-05	9.77e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.66e-05	9.77e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP1B1—ovarian cancer	1.62e-05	9.56e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CG—ovarian cancer	1.6e-05	9.42e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.58e-05	9.34e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ABCB1—ovarian cancer	1.58e-05	9.29e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—TYMS—ovarian cancer	1.55e-05	9.13e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CAV1—ovarian cancer	1.52e-05	8.96e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CG—ovarian cancer	1.51e-05	8.9e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.45e-05	8.56e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—AKT1—ovarian cancer	1.45e-05	8.56e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	1.44e-05	8.48e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.43e-05	8.44e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CD—ovarian cancer	1.41e-05	8.28e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CG—ovarian cancer	1.38e-05	8.16e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—FASN—ovarian cancer	1.37e-05	8.1e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CAV1—ovarian cancer	1.36e-05	8e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.35e-05	7.97e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ABCB1—ovarian cancer	1.34e-05	7.87e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CD—ovarian cancer	1.33e-05	7.82e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—TYMS—ovarian cancer	1.31e-05	7.73e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.31e-05	7.7e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.3e-05	7.64e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.25e-05	7.38e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CAV1—ovarian cancer	1.25e-05	7.36e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CG—ovarian cancer	1.24e-05	7.28e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CB—ovarian cancer	1.22e-05	7.22e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CD—ovarian cancer	1.22e-05	7.17e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CB—ovarian cancer	1.16e-05	6.82e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	1.14e-05	6.7e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.11e-05	6.54e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CD—ovarian cancer	1.09e-05	6.4e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CB—ovarian cancer	1.06e-05	6.25e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTEN—ovarian cancer	1.06e-05	6.24e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CAV1—ovarian cancer	1.06e-05	6.23e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.03e-05	6.08e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—TYMS—ovarian cancer	1.01e-05	5.97e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.01e-05	5.95e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTEN—ovarian cancer	1e-05	5.89e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	9.99e-06	5.89e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CG—ovarian cancer	9.63e-06	5.68e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CB—ovarian cancer	9.47e-06	5.58e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTEN—ovarian cancer	9.17e-06	5.4e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	8.71e-06	5.13e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CD—ovarian cancer	8.47e-06	4.99e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTEN—ovarian cancer	8.18e-06	4.82e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CAV1—ovarian cancer	8.16e-06	4.81e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTEN—ovarian cancer	7.53e-06	4.44e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CA—ovarian cancer	7.47e-06	4.4e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	7.43e-06	4.38e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CB—ovarian cancer	7.38e-06	4.35e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CA—ovarian cancer	7.05e-06	4.16e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	6.53e-06	3.85e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CA—ovarian cancer	6.47e-06	3.81e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTEN—ovarian cancer	6.38e-06	3.76e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—AKT1—ovarian cancer	6.1e-06	3.6e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CA—ovarian cancer	5.77e-06	3.4e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—AKT1—ovarian cancer	5.76e-06	3.4e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	5.69e-06	3.36e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	5.31e-06	3.13e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—AKT1—ovarian cancer	5.28e-06	3.11e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTEN—ovarian cancer	4.92e-06	2.9e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—AKT1—ovarian cancer	4.72e-06	2.78e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CA—ovarian cancer	4.5e-06	2.65e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—AKT1—ovarian cancer	4.34e-06	2.56e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—AKT1—ovarian cancer	3.67e-06	2.17e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	3.47e-06	2.05e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—AKT1—ovarian cancer	2.84e-06	1.67e-05	CbGpPWpGaD
